PlainPill

Palmitoylethanolamide

The short answer. There isn't much data on Palmitoylethanolamide yet — 46 mentions, 10 with a clear outcome — so treat these numbers as anecdotal. It is most often used for pain & inflammation: 91% of 11 reports say that improved. It is well studied — 28 meta-analyses on PubMed.

What users report
81%helped10 reports · few reports
8 helped1 mixed1 didn't help

From 46 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
28
meta-analyses
69
RCTs
1,194
papers

What Palmitoylethanolamide does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 28 meta-analyses on PubMed ↗ · 69 randomized trials ↗

Nutrients · 2023 · Meta-analysis / systematic review
Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials

Conclusion: The results of this systematic review and meta-analysis suggest that PEA is an effective and well-tolerated treatment for chronic pain. Further study is warranted to determine the optimal dosing and administration parameters of PEA for analgesic effects in the context of chronic pain.

PubMed 36986081 ↗
J Psychopharmacol · 2025 · Meta-analysis / systematic review
Navigating agitation in neurodevelopmental disorders: A comparative study of pharmacotherapies via network meta-analysis in children and adults with autism spectrum disorder or intellectual disabilities

Conclusion: This study underscores the efficacy and tolerability of several pharmacotherapies in managing agitation among children and adults with ASD or ID. Our findings provide robust evidence that specific treatments, such as arbaclofen, risperidone plus buspirone and omega-3 fatty acids, are both effective and well-tolerated, offering valuable therapeutic options for clinicians. The study emphasizes the need for ongoing research to ensure that treatment strategies remain aligned with the evolving clinical landscape, ultimately improving patient outcomes in this challenging population.

PubMed 39690490 ↗
Nat Prod Res · 2025 · Meta-analysis / systematic review
Evaluation of the nutraceutical Palmitoylethanolamide in reducing intraocular pressure (IOP) in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis

Conclusion: Six of these studies (199 patients) were included in the systematic review after the study selection process, and three studies for meta-analysia. Overall, PEA showed significant efficacy in reducing IOP in patients, this encourages its clinical use in glaucoma as well as across different forms of eye disorders.

PubMed 38269580 ↗
Registered clinical trials

69 human trials on ClinicalTrials.gov test Palmitoylethanolamide — 33 completed, 12 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US government research funding (NIH)

NIH has funded 1 research project with Palmitoylethanolamide in the title, $2,051,325 in total (2023–2024). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

600 mgtwice daily
800 mg2x daily
2 gdaily

Reported side effects

How often each side effect came up across all reports.

stomach issues ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“Just started taking Palmitoylethanolamide and have had some wonderful effects. Sleeping is easier and i feel more comfortable trying to fall asleep.”
HelpedRead the discussion ↗
“For the past few months she has been on PEA, 600mg b.i.d. ... Not only has her energy, pain, and skin improved dramatically”
MixedRead the discussion ↗
“this stuff works so well. It treats inflammation and several types of hard to treat nerve pain such as fibromyalgia, and shingles. I use it for rosacea.”
HelpedRead the discussion ↗
“I already take PEA (palmitoylethanolamide) daily and that helps me keep my general sleep schedule and overall sleep health”
HelpedRead the discussion ↗
Read more Palmitoylethanolamide reviews →
Top discussions (5)

Other options for pain & inflammation

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate